Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism

Código QR

Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism

Guardado en:

Detalles Bibliográficos
Autores principales:	Marko Lucijanic, Ivan Krecak, Ena Soric, Martina Sedinic, Anica Sabljic, Lovorka Derek, Ozren Jaksic, Rajko Kusec
Formato:	article
Lenguaje:	EN
Publicado:	Nature Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/132774046f3f4b67ab77267a714f00ba
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms
por: Jinyong Kim, et al.
Publicado: (2021)

Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
por: Magdalena M. Brune, et al.
Publicado: (2021)

FREQUENCY OF TET2 GENE MUTATION IN MYELOPROLIFERATIVE NEOPLASMS
por: Syed Owais Ali, et al.
Publicado: (2021)

ESSENTIAL THROMBOCYTOSIS IN CHILDREN
por: Canan ALBAYRAK, et al.
Publicado: (2021)

Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing
por: Arti Easwar, et al.
Publicado: (2021)

A Risk of Venous Thromboembolism Algorithm as a Predictor of Venous Thromboembolism in Patients with Colorectal Cancer
por: Ying Chen MB, et al.
Publicado: (2021)

Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients
por: Joan How, et al.
Publicado: (2021)

More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features
por: Lucijanic M, et al.
Publicado: (2021)

Platelets Contribution to Thrombin Generation in Philadelphia-Negative Myeloproliferative Neoplasms: The “Circulating Wound” Model
por: Alessandro Lucchesi, et al.
Publicado: (2021)

Progression in Ph-Chromosome-Negative Myeloproliferative Neoplasms: An Overview on Pathologic Issues and Molecular Determinants
por: Elena Sabattini, et al.
Publicado: (2021)

New Horizons in Myeloproliferative Neoplasms Treatment: A Review of Current and Future Therapeutic Options
por: Domenico Penna
Publicado: (2021)

The Classification of Myeloproliferative Neoplasms: Rationale, Historical Background and Future Perspectives with Focus on Unclassifiable Cases
por: Marco Pizzi, et al.
Publicado: (2021)

A portable microfluidic platform for rapid molecular diagnostic testing of patients with myeloproliferative neoplasms
por: Hua Wang, et al.
Publicado: (2017)

THE OUTCOME OF FATHERHOOD IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS, A SINGLE INSTITUTION EXPERIENCE
por: Elrazi Ali, et al.
Publicado: (2021)

Prevalence of Asymptomatic Venous Thromboembolism in Depressive Inpatients
por: Takeshima M, et al.
Publicado: (2020)

Prevention and treatment of venous thromboembolism in the elderly patient
por: Enrico Tincani, et al.
Publicado: (2007)

Venous Thromboembolism in Japanese Patients With Pancreatic Cancer
por: Takahito Suzuki MD, et al.
Publicado: (2021)

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
por: Hans C. Hasselbalch, et al.
Publicado: (2021)

Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature
por: Juri Alessandro Giannotta, et al.
Publicado: (2021)

Thromboprophylaxis Measures to Prevent Venous Thromboembolism in Hospitalized Patients
por: Dilceu Silveira Tolentino Júnior, et al.
Publicado: (2020)

RNA expression and risk of venous thromboembolism in lung cancer
por: Tamara A. Sussman, et al.
Publicado: (2020)

Rivaroxaban in acute venous thromboembolism: UK prescribing experience
por: Victoria Speed, et al.
Publicado: (2021)

Primary prevention of venous thromboembolism in elderly medical patients
por: Karine Lacut, et al.
Publicado: (2008)

Predicting perioperative venous thromboembolism in Japanese gynecological patients.
por: Masae Ikeda, et al.
Publicado: (2014)

A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasm
por: D. A. Casolari, et al.
Publicado: (2017)

Improved diagnosis of the transition to JAK2 (V⁶¹⁷F) homozygosity: the key feature for predicting the evolution of myeloproliferative neoplasms.
por: Mariana Selena Gonzalez, et al.
Publicado: (2014)

A Case of Thrombocytosis Associated with Enoxaparin Therapy in an Adolescent
por: Murray R, et al.
Publicado: (2021)

Venous thromboembolism in patients hospitalized for knee joint replacement surgery
por: Karsten Keller, et al.
Publicado: (2020)

Management of Venous Thromboembolism in Children: Current Recommendations and Therapeutic Options
por: Bosch A, et al.
Publicado: (2020)

Incidence of venous thromboembolism in psychiatric inpatients: a chart review
por: Takeshima M, et al.
Publicado: (2018)

Impact of Pregnancy-Related Venous Thromboembolism on Quality of Patients’ Lives
por: Naser Al-Husban MD, FRCOG, et al.
Publicado: (2021)

In vitro megakaryocyte differentiation and proplatelet formation in Ph-negative classical myeloproliferative neoplasms: distinct patterns in the different clinical phenotypes.
por: Alessandra Balduini, et al.
Publicado: (2011)

A Cross-sectional Study of Patients and Physicians on the Impact of Myeloproliferative Neoplasms on Patient Health: The Landmark Survey From Taiwan
por: Cheng-Shyong Chang, et al.
Publicado: (2021)

Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review
por: Qiyan Cai, et al.
Publicado: (2021)

The Clinical Pharmacist assessment in the prophylaxis of venous thromboembolism in a university hospital
por: Julia S. GOMES, et al.
Publicado: (2021)

Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism
por: Di W, et al.
Publicado: (2021)

Mean platelet volume as a prognostic factor for venous thromboembolic disease
por: Díaz,Juan Manuel, et al.
Publicado: (2019)

Acute Limb Ischemia in the Young: A Rare Case of Essential Thrombocytosis
por: Johanes Nugroho, et al.
Publicado: (2021)

Prediction of venous thromboembolism with machine learning techniques in young-middle-aged inpatients
por: Hua Liu, et al.
Publicado: (2021)

PICO Questions and DELPHI Methodology for the Management of Venous Thromboembolism Associated with COVID-19
por: Antoni Riera-Mestre, et al.
Publicado: (2021)